LINCOLN CAPITAL CORP - TONIX PHARMACEUTICALS HLDG C ownership

Quarter-by-quarter ownership
LINCOLN CAPITAL CORP ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2021$11,000
-26.7%
10,000
-16.7%
0.01%
-33.3%
Q1 2021$15,00012,0000.01%
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q3 2023.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders